Arcus Biosciences Inc (RCUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 150,000 | 201,000 | 156,000 | 185,000 | 127,000 |
| Marketable Securities | 828,000 | 888,000 | 813,000 | 810,000 | 632,000 |
| Receivables | 20,000 | 16,000 | 28,000 | 35,000 | 38,000 |
| TOTAL | $1,016,000 | $1,127,000 | $1,022,000 | $1,064,000 | $831,000 |
| Non-Current Assets | |||||
| PPE Net | 47,000 | 48,000 | 49,000 | 51,000 | 51,000 |
| Investments And Advances | 14,000 | 2,000 | 40,000 | 100,000 | 107,000 |
| Other Non-Current Assets | 73,000 | 75,000 | 75,000 | 78,000 | 106,000 |
| TOTAL | $134,000 | $125,000 | $164,000 | $229,000 | $264,000 |
| Total Assets | $1,150,000 | $1,252,000 | $1,186,000 | $1,293,000 | $1,095,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,000 | 13,000 | 15,000 | 16,000 | 17,000 |
| Other current liabilities | 123,000 | 97,000 | 71,000 | 64,000 | 76,000 |
| TOTAL | $226,000 | $215,000 | $199,000 | $204,000 | $184,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 48,000 | 47,000 | N/A | N/A | N/A |
| Deferred Revenues | 85,000 | 105,000 | 113,000 | 124,000 | 91,000 |
| Other Non-Current Liabilities | 157,000 | 136,000 | 138,000 | 140,000 | 142,000 |
| TOTAL | $439,000 | $472,000 | $352,000 | $382,000 | $449,000 |
| Total Liabilities | $665,000 | $687,000 | $551,000 | $586,000 | $633,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 105,841 | 91,512 | 91,428 | 90,953 | 90,865 |
| Common Shares | 1,617,000 | 1,602,000 | 1,582,000 | 1,561,000 | 1,311,000 |
| Retained earnings | -1,132,000 | -1,038,000 | -946,000 | -853,000 | -849,000 |
| Other shareholders' equity | 0 | 1,000 | -1,000 | -1,000 | 0 |
| TOTAL | $485,000 | $565,000 | $635,000 | $707,000 | $462,000 |
| Total Liabilities And Equity | $1,150,000 | $1,252,000 | $1,186,000 | $1,293,000 | $1,095,000 |